Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MikeStockon Apr 09, 2021 8:20am
162 Views
Post# 32965276

RE:RE:Thank you

RE:RE:Thank youYou guys do realize that you keep saying the same thing, but you just push the timeline out right? 

I love this stock and this board and enjoy reading all of the comments and debate, but it's funny that last fall everyone kept saying January is our time. Going to the NAZ, IND, corporate update. Hold your shares. It's going to be great. 

January came and everyone kept saying. The plan is in motion. Just wait until the end of the quarter. It's going to be great. IND, complete the amalgmation. 

Now everyone is saying, the fall!  The fall is where it's at.  This is the plan. Dan is the man. A master at the helm. Hold your shares. It's going to be great. 

I am holding my shares and everything to me makes sense except for why rush the RS if they weren't going to go the big show until 10 months later. I asked  Christina that question and got a non-answer back. 

I also asked her when the amalgamation will be complete. She said April (a lot of paperwork). So hopefully in less than 3 weeks we have our answer on that. 

Happy Friday folks. I'll be watching golf this afternoon.


<< Previous
Bullboard Posts
Next >>